Quality of life in prostate cancer patients taking androgen deprivation therapy.

@article{Dacal2006QualityOL,
  title={Quality of life in prostate cancer patients taking androgen deprivation therapy.},
  author={Kirsten Dacal and Susan M. Sereika and Susan L. Greenspan},
  journal={Journal of the American Geriatrics Society},
  year={2006},
  volume={54 1},
  pages={85-90}
}
OBJECTIVES To examine the effect of androgen deprivation therapy (ADT) on health-related quality of life (HRQOL), self-reported HRQOL was compared in prostate cancer patients receiving short- (< 6 months) or long-term (> or = 6 months) ADT and healthy controls. DESIGN Cross-sectional study. SETTING Academic medical center in Pittsburgh, Pennsylvania. PARTICIPANTS Ninety-six men, including those with prostate cancer receiving short-term, long-term, and no ADT and healthy controls. Men… CONTINUE READING